[T-cell lymphoblastic lymphomas. Clinico-pathological study of 17 cases and short- and long-term therapeutic responses].
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008228:Lymphoma, Non-Hodgkin / Q000556:secondary / Q000628:therapy*; D008297:Male; D008479:Mediastinal Neoplasms / Q000628:therapy*; D008577:Meningeal Neoplasms / Q000556:secondary; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D013601:T-Lymphocytes; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
Linfomas T linfoblásticos. Estudio clínico-patológico de 17 casos y respuesta terapéutica a corto y largo plazo.